Report Highlights

The global nanomedicine market reached $43.2 billion in 2010 and $50.1 billion in 2011. The market is expected to grow to $96.9 billion by 2016 at a compound annual growth rate (CAGR) of 14.1% between years 2011 and 2016.

SCOPE OF REPORT

This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry is discussed with profiles of the leading 60+ companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

ANALYST CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous reports on the nanomedicine marketplace as well as analyses of major therapeutic categories and the pharmaceutical regulatory environment.